Is Vaishali Pharma Ltd debt-free?

Yes, Vaishali Pharma Ltd is debt-free with a debt-to-equity ratio of 0.19.

Home

Vaishali Pharma Ltd

Vaishali Pharma Ltd Financials

Vaishali Pharma Ltd Financial Statement

Vaishali Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	24.59	33.25	28.98
Operating Expense	22.38	38.29	26.55
Net Profit	1.28	-4.29	1.44
Net Profit Margin	5.21	-12.90	4.97
Earning Per Share	0.10	-0.33	0.98
EBIDTA	2.19	-5.03	2.42
Effective Tax Rate	19.91	25.79	19.75

Particulars	Jun 2025
Revenue	24.59
Operating Expense	22.38
Net Profit	1.28
Net Profit Margin	5.21
Earning Per Share	0.10
EBIDTA	2.19
Effective Tax Rate	19.91

Vaishali Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	99.03	86.28	69.66
Operating Expenses Annual	98.94	85.14	60.53
Operating Profit Annual	3.30	3.17	11.36
Interest Annual	1.58	1.74	2.01
Depreciation	0.35	0.38	0.40
Net Profit Annual	0.82	0.72	6.60
Tax Annual	0.41	0.21	2.24

Particulars	Mar 2025
Total Revenue Annual	99.03
Operating Expenses Annual	98.94
Operating Profit Annual	3.30
Interest Annual	1.58
Depreciation	0.35
Net Profit Annual	0.82
Tax Annual	0.41

Vaishali Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	1.58	0.98	1.36
Cash Flow from Operations	-18.04	0.81	1.08
Cash Flow from Investing	-0.19	1.20	0.28
Cash Flow from Financing	18.49	-1.42	-1.73
Cash Flow at the End	1.84	1.58	0.98

Particulars	Mar 2025
Cash Flow at the Beginning	1.58
Cash Flow from Operations	-18.04
Cash Flow from Investing	-0.19
Cash Flow from Financing	18.49
Cash Flow at the End	1.84

Vaishali Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	4.29	16.67	11.43
PBIT Margin (%)	3.70	15.95	10.83
PBT Margin (%)	2.07	8.90	6.48
Net PROFIT Margin (%)	0.83	9.47	5.30
Return On Networth / Equity (%)	1.73	19.73	16.48
Return On Networth /Employed (%)	5.71	21.59	18.70
Return On Assets (%)	1.29	12.89	9.17
Total Debt / Equity (X)	0.34	0.53	0.79
Asset Turnover Ratio (%)	1.54	1.36	1.73

Particulars	Mar 2024
PBDIT Margin (%)	4.29
PBIT Margin (%)	3.70
PBT Margin (%)	2.07
Net PROFIT Margin (%)	0.83
Return On Networth / Equity (%)	1.73
Return On Networth /Employed (%)	5.71
Return On Assets (%)	1.29
Total Debt / Equity (X)	0.34
Asset Turnover Ratio (%)	1.54

Vaishali Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	2.08	2.26	2.65
Total Current Assets Annual	104.48	74.52	72.67
Non Current Assets Annual	5.36	5.44	6.23
Total Shareholders Funds Annual	64.92	42.84	40.53
Total Assets Annual	109.84	79.96	78.90

Particulars	Mar 2025
Fixed Assets Annual	2.08
Total Current Assets Annual	104.48
Non Current Assets Annual	5.36
Total Shareholders Funds Annual	64.92
Total Assets Annual	109.84

Vaishali Pharma Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Vaishali Pharma Ltd Financials

As of Sep 16, 2025, Vaishali Pharma Ltd has a market capitalization of 134.85 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vaishali Pharma Ltd is with a debt-to-equity ratio of 0.19.

In FY 2024 , Vaishali Pharma Ltd recorded a total revenue of approximately 99.03 Cr marking a significant milestone in the company's financial performance.

Vaishali Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.2% annually, respectively..

Vaishali Pharma Ltd's current PE ratio is 164.45.

Vaishali Pharma Ltd's ROCE averaged 9.3% from the FY ending March 2023 to 2025, with a median of 4.7%. It peaked at 19.6% in March 2023, reflecting strong capital efficiency over the period..

Vaishali Pharma Ltd's latest EBIT is Rs. 2.81 Cr, surpassing the average EBIT of Rs. 5.45 Cr over the 5 years..